Cargando…

Role of IgM and IgA Antibodies in the Neutralization of SARS-CoV-2

BACKGROUND: SARS-CoV-2 has infected millions of people globally. Virus infection requires the receptor-binding domain (RBD) of the spike protein. Although studies have demonstrated anti-spike and - RBD antibodies to be protective in animal models, and convalescent plasma as a promising therapeutic o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Klingler, Jéromine, Weiss, Svenja, Itri, Vincenza, Liu, Xiaomei, Oguntuyo, Kasopefoluwa Y., Stevens, Christian, Ikegame, Satoshi, Hung, Chuan-Tien, Enyindah-Asonye, Gospel, Amanat, Fatima, Baine, Ian, Arinsburg, Suzanne, Bandres, Juan C., Kojic, Erna Milunka, Stoever, Jonathan, Jurczyszak, Denise, Bermudez-Gonzalez, Maria, Nádas, Arthur, Liu, Sean, Lee, Benhur, Zolla-Pazner, Susan, Hioe, Catarina E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7654883/ https://www.ncbi.nlm.nih.gov/pubmed/33173891 http://dx.doi.org/10.1101/2020.08.18.20177303

Ejemplares similares

Role of Immunoglobulin M and A Antibodies in the Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2
por: Klingler, Jéromine, et al.
Publicado: (2020)

A High-Throughput Assay for Circulating Antibodies Directed Against the S Protein of Severe Acute Respiratory Syndrome Coronavirus 2
por: Weiss, Svenja, et al.
Publicado: (2020)

A HIGH THROUGH-PUT ASSAY FOR CIRCULATING ANTIBODIES DIRECTED AGAINST THE S PROTEIN OF SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-CoV-2)
por: Weiss, Svenja, et al.
Publicado: (2020)

Detection of Antibody Responses against SARS-CoV-2 in Plasma and Saliva from Vaccinated and Infected Individuals
por: Klingler, Jéromine, et al.
Publicado: (2021)

Detection of Antibody Responses Against SARS-CoV-2 in Plasma and Saliva From Vaccinated and Infected Individuals
por: Klingler, Jéromine, et al.
Publicado: (2021)

Immune profiles to distinguish hospitalized versus ambulatory COVID-19 cases in older patients
por: Klingler, Jéromine, et al.
Publicado: (2022)

The IgA in milk induced by SARS-CoV-2 infection is comprised of mainly secretory antibody that is neutralizing and highly durable over time
por: Fox, Alisa, et al.
Publicado: (2022)

Immune Complex Vaccine Strategies to Combat HIV-1 and Other Infectious Diseases
por: Tang, Alex F., et al.
Publicado: (2021)

Quantifying absolute neutralization titers against SARS-CoV-2 by a standardized virus neutralization assay allows for cross-cohort comparisons of COVID-19 sera
por: Oguntuyo, Kasopefoluwa Y., et al.
Publicado: (2020)

Quantifying Absolute Neutralization Titers against SARS-CoV-2 by a Standardized Virus Neutralization Assay Allows for Cross-Cohort Comparisons of COVID-19 Sera
por: Oguntuyo, Kasopefoluwa Y., et al.
Publicado: (2021)

CD6 expression has no effect on atherosclerosis in apolipoprotein E-deficient mice
por: Han, Juying, et al.
Publicado: (2018)

Proteases and variants: context matters for SARS-CoV-2 entry assays
por: Stevens, Christian S, et al.
Publicado: (2021)

Alveolar Macrophage Dysfunction and Increased PD-1 Expression During Chronic SIV Infection of Rhesus Macaques
por: Hunegnaw, Ruth, et al.
Publicado: (2019)

Robust and Specific Secretory IgA Against SARS-CoV-2 Detected in Human Milk
por: Fox, Alisa, et al.
Publicado: (2020)

Replicating Adenovirus-SIV Immunization of Rhesus Macaques Induces Mucosal Dendritic Cell Activation and Function Leading to Rectal Immune Responses
por: Ko, Eun-Ju, et al.
Publicado: (2019)

Impact of IgG Isotype on the Induction of Antibody-Dependent Cellular Phagocytosis of HIV by Human Milk Leukocytes
por: Fox, Alisa, et al.
Publicado: (2022)

Non-neutralizing Antibodies Targeting the V1V2 Domain of HIV Exhibit Strong Antibody-Dependent Cell-mediated Cytotoxic Activity
por: Mayr, Luzia M., et al.
Publicado: (2017)

Vaccination with immune complexes modulates the elicitation of functional antibodies against HIV-1
por: Hioe, Catarina E., et al.
Publicado: (2023)

Indirect Detection of an Epitope-Specific Response to HIV-1 gp120 Immunization in Human Subjects
por: Shmelkov, Evgeny, et al.
Publicado: (2011)

A Mucosal Adenovirus Prime/Systemic Envelope Boost Vaccine Regimen Elicits Responses in Cervicovaginal and Alveolar Macrophages of Rhesus Macaques Associated With Delayed SIV Acquisition and B Cell Help
por: Hunegnaw, Ruth, et al.
Publicado: (2020)

Skin tattooing as an effective tool for delivering DNA and protein vaccine immunogens
por: Chiu, Y, et al.
Publicado: (2012)

P04-55 LB. Anti-V3 monoclonal antibodies display broad neutralizing activities against multiple HIV-1 subtypes
por: Zolla-Pazner, S, et al.
Publicado: (2009)

Overexpression of CD6 and PD-1 Identifies Dysfunctional CD8(+) T-Cells During Chronic SIV Infection of Rhesus Macaques
por: Enyindah-Asonye, Gospel, et al.
Publicado: (2020)

Crystal structure and solution state of the C-terminal head region of the narmovirus receptor binding protein
por: Stelfox, Alice J., et al.
Publicado: (2023)

Neutralizing activity of Sputnik V vaccine sera against SARS-CoV-2 variants
por: Ikegame, Satoshi, et al.
Publicado: (2021)

Neutralizing activity of Sputnik V vaccine sera against SARS-CoV-2 variants
por: Ikegame, Satoshi, et al.
Publicado: (2021)

Optimized protocol for detection of native, full‐length HIV‐1 envelope on the surface of transfected cells
por: Altman, J.B., et al.
Publicado: (2018)

Alterations of HIV-1 envelope phenotype and antibody-mediated neutralization by signal peptide mutations
por: Upadhyay, Chitra, et al.
Publicado: (2018)

Sendai virus, an RNA virus with no risk of genomic integration, delivers CRISPR/Cas9 for efficient gene editing
por: Park, Arnold, et al.
Publicado: (2016)

A Pathogenic Role for Splenic B1 Cells in SIV Disease Progression in Rhesus Macaques
por: Enyindah-Asonye, Gospel, et al.
Publicado: (2019)

Signal peptide of HIV-1 envelope modulates glycosylation impacting exposure of V1V2 and other epitopes
por: Upadhyay, Chitra, et al.
Publicado: (2020)

Mucosal-associated invariant T (MAIT) cells provide B-cell help in vaccinated and subsequently SIV-infected Rhesus Macaques
por: Rahman, Mohammad Arif, et al.
Publicado: (2020)

Functional Antibody Response Against V1V2 and V3 of HIV gp120 in the VAX003 and VAX004 Vaccine Trials
por: Balasubramanian, Preetha, et al.
Publicado: (2018)

Neutralizing activity of Sputnik V vaccine sera against SARS-CoV-2 variants
por: Ikegame, Satoshi, et al.
Publicado: (2021)

Non-neutralizing IgG anti-PID antibodies decreased viral load following high dose vaginal challenge of non-human primates
por: Moog, C, et al.
Publicado: (2012)

Rationally Targeted Mutations at the V1V2 Domain of the HIV-1 Envelope to Augment Virus Neutralization by Anti-V1V2 Monoclonal Antibodies
por: Shen, Guomiao, et al.
Publicado: (2015)

Modulation of Antibody Responses to the V1V2 and V3 Regions of HIV-1 Envelope by Immune Complex Vaccines
por: Hioe, Catarina E., et al.
Publicado: (2018)

Rapid, early, and potent Spike-directed IgG, IgM, and IgA distinguish asymptomatic from mildly symptomatic COVID-19 in Uganda, with IgG persisting for 28 months
por: Serwanga, Jennifer, et al.
Publicado: (2023)

A serological assay to detect SARS-CoV-2 seroconversion in humans
por: Amanat, Fatima, et al.
Publicado: (2020)

Identifying epitopes of HIV-1 that induce protective antibodies
por: Zolla-Pazner, Susan
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_k9efqai6eh3oea6tvnr3326dkk